Sort
8,912 grants matching “sars cov 2”
A COVID-19 Point of Care Serological Assay for Rapid Quantification of Antibody Titer.
$398,753Alberto Gandini · Accel Diagnostics, Llc · R44 · FY2024 · AI
Impact of SARS CoV2 on post-hospital recovery of carbohydrate and muscle metabolism: role of endothelial injury
$398,573Jane E Reusch · University Of Colorado Denver · R01 · FY2021 · DK
Real-world impact of the COVID-19 pandemic in people with multiple sclerosis
$398,445Zongqi Xia · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · NS
Memorialization, Contested Knowledge, and the Sociopsychological Impacts of Disinformation in the Context of COVID-19
$398,317Sarah E Wagner · George Washington University · · FY2022 · SBE
Nanopore Methods for Determining Capsid Viability
$398,075Kimberly Ritola · Univ Of North Carolina Chapel Hill · R01 · FY2023 · FD
RNA Recombination in Coronaviruses
$398,043Andrew Laurence Routh · Scripps Research Institute, The · R01 · FY2023 · AI
Expansion and characterization of the Drosophila Toolkit to study SARS-CoV-2
$398,040Hugo J Bellen · Baylor College Of Medicine · R24 · FY2022 · OD
Full-length sequencing of individual RNAs from heterogeneous samples
$398,040William S Agnew · Phaeno Inc · R43 · FY2022 · HG
Virus-Like Particle Vaccine for SARS-CoV
$397,807Raphael Paul Viscidi · Johns Hopkins University · R01 · FY2007 · AI
Metallothionein 1E as a Central Regulator of Human Pancreatic Beta Cell Function and Survival
$397,733Shuibing Chen · Weill Medical Coll Of Cornell Univ · R01 · FY2020 · DK
Markov State Model approaches for folding, binding and design
$397,593Vincent Voelz · Temple Univ Of The Commonwealth · R01 · FY2022 · GM
SARS-CoV-2 infection of non-human primates
$397,520Daniel Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Mechanistic Studies of Gut Dysfunction Exacerbation due to SARS-CoV-2 in HIV/SIV infected Individuals
$397,500Ivona Pandrea · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · DK
Vaccines, Immunoprophylaxis, and Immunotherapy for SARS
$397,437Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Design and evaluation of a multivalent nanobody construct for prevention or treatment of SARS-CoV-2
$397,382Julie Champion · Georgia Institute Of Technology · R21 · FY2021 · EB
Clinical Core
$397,182Philip C Mack · Icahn School Of Medicine At Mount Sinai · U54 · FY2022 · CA
Engaging community Members to Plan for dissemination Of Wastewater Epidemiology Results (The EMPOWER Study)
$397,000Amy Lynn McGuire · Baylor College Of Medicine · R01 · FY2025 · ES
Mechanistic Studies of Gut Dysfunction Exacerbation due to SARS-CoV-2 in HIV/SIV infected Individuals
$396,980Ivona Pandrea · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · DK
Modeling Core
$396,655Luis A. Nunes Amaral · Northwestern University At Chicago · U19 · FY2023 · AI
Development of Next Generation Plasmonic Nanosensors for Ultrasensitive, High-Throughput Nucleic Acid and Protein Assays
$396,638Rajesh Sardar · Indiana University · · FY2022 · ENG
Role of Uncharacterized Genes in High Pathogenic Human Coronavirus Infection
$396,549Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2017 · AI
Cellular Immunity and Memory to SARS-CoV-2
$396,512Elizabeth B Norton · Tulane University Of Louisiana · U54 · FY2022 · CA
CORALE-SeroNet Recruitment and Biobanking Core
$396,401Jane C. Figueiredo · Cedars-Sinai Medical Center · U54 · FY2022 · CA
Biophysics of Macromolecular Complexes
$396,360Gary Felsenfeld · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
PROJECT 2: INNATE IMMUNITY
$396,354Rafi Ahmed · Emory University · U19 · FY2024 · AI